Examples of using Lassa in English and their translations into Malay
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
You have to save Lassa.
Lassa fever is an acute viral haemorrhagic illness of 1-4 weeks duration that occurs in West Africa.
There is no vaccine for Lassa fever.
Lassa virus infections can only be diagnosed definitively in the laboratory using the following tests.
There is as yet no vaccine for Lassa Fever.
People also translate
Lassa fever is an acute viral haemorrhagic illness caused by Lassa virus, a member of the arenavirus family of viruses.
The incubation period for Lassa Fever is 6-21 days.
We currently do not have a vaccine to protect against Lassa fever.
The antiviral drugribavirin seems to be an effective treatment for Lassa fever if given early on in the course of clinical illness.
There is no evidence to support therole of ribavirin as post-exposure prophylactic treatment for Lassa fever.
About 80% of people infected with Lassa virus have no symptoms.
Because the symptoms of Lassa fever are so varied and non-specific, clinical diagnosis is often difficult, especially early in the course of the disease.
Unfortunately, there is no vaccine for Lassa fever yet.
Health workers are at risk if caring for Lassa fever patients in the absence of proper barrier nursing and infection control practices.
For now, there is no vaccine for preventing Lassa fever.
In addition, a new ward dedicated to the care of patients with Lassa fever is under construction in Sierra Leone, sponsored by the European Union.
Currently, no known vaccine protects against Lassa fever.
Laboratory samples taken to investigate the Lassa virus infection should be handled by trained staff and processed in suitably equipped laboratories.
Currently, there is no vaccine to protect against Lassa fever.
From humans and animals for investigation of Lassa virus infection should be handled by trained staff and processed in suitably equipped laboratories.
About 80% of the people who are infected with Lassa virus have no symptoms.
Lassa virus may also be spread between humans through direct contact with the blood, urine, feces or other bodily secretions of a person infected with Lassa fever.
Eighty percent of persons infected with Lassa virus have no symptoms.
Samples taken from humans and animals for investigation of Lassa virus infection should be handled by trained staff and processed in suitably equipped laboratories under maximum biological containment conditions.
Observed case-fatality rate among patients hospitalized with severe cases of Lassa fever is 15%.
Health-care workers seeing a patient suspected to have Lassa fever should immediately contact local and national experts for advice and to arrange for laboratory testing.
The programme supports these three countries in developing national prevention strategies andenhancing laboratory diagnostics for Lassa fever and other dangerous diseases.
Lassa fever is known to be endemic in Benin(where it was diagnosed for the first time in November 2014), Guinea, Liberia, Mali, Sierra Leone and parts of Nigeria, but probably exists in other West African countries as well.
Although malaria, typhoid fever, and many other tropical infections are much more common, the diagnosis of Lassa fever should be considered in febrile patients returning from West Africa, especially if they have had exposures in rural areas or hospitals in countries where Lassa fever is known to be endemic.
